TCM
DXCM icon

Tuttle Capital Management’s DexCom DXCM Stock Holding History

Tuttle Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,236
Closed -$429K – 147
2020
Q2 		$429K Buy
+4,236
New +$379K 0.31% 75
2019
Q3 		– Sell
-43,144
Closed -$1.62M – 249
2019
Q2 		$1.62M Buy
+43,144
New +$1.36M 0.63% 44

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Tuttle Capital Management's DXCM Position: Q3 2020 in Review

Tuttle Capital Management sold out of DexCom (DXCM) in Q3 2020, closing a stake of 4,236 shares — an estimated $429K sold.

Tuttle Capital Management first reported a position in DXCM in Q2 2019 and held it in 2 quarters. The position peaked at $1.62M in Q2 2019. 728 funds tracked by Wall St. Rank hold DXCM as of Q3 2020.

  • Tuttle Capital Management reported no remaining DexCom position as of Q3 2020 after selling out during the quarter.
  • Tuttle Capital Management sold 4,236 DexCom shares in Q3 2020, an estimated $429K.
  • Tuttle Capital Management first reported a position in DexCom in Q2 2019 and held it in 2 quarters.
  • Tuttle Capital Management's DexCom position peaked at $1.62M in Q2 2019.
  • 728 funds tracked by Wall St. Rank held DexCom as of Q3 2020.

Based on Tuttle Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.